Attachment B - Vendor Feedback Form.pdf
PDF 143 KB Posted
- Attached to
- Research and Development of the FDA ARGOS System
- Solicitation number
- FDA-SSN-75F40125Q00090
About this file
The Vendor Feedback Form is a two-page document associated with the FDA's Sources Sought Notice for the Research and Development of the FDA ARGOS System. The form is designed to collect detailed information from potential vendors about their capabilities, experience, and qualifications for a contract focused on developing analytical tools, genetic and epigenetic datasets for regulatory science and pandemic preparedness.
The form requires vendors to provide comprehensive details including: capability to deliver all requested services, existing contract vehicles, specific experience across eight potential task areas, NAICS code recommendations, and GSA schedule contract information. Vendors are asked to respond to 16 distinct questions covering their technical expertise, past performance, and alignment with the FDA's objectives for enhancing the ARGOS database and developing tools for in-silico performance validation of infectious disease Next Generation Sequencing (NGS) technologies. Responses are due by May 2, 2025, at 2:00 pm EST, with a maximum 15-page response limit, and will be used by the FDA to determine potential sources for a future solicitation.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Attachment A-STATEMENT OF OBJECTIVES for IDIQ.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Attachment B - Vendor Feedback Form
Vendor/Company Name:
1. Is your company capable of providing all the requested services found within the Draft STATEMENT
OF OBJECTIVES (SOO)? If NO is selected, which service(s) is/are your company not able to provide?
☐ YES ☐ NO
2. Does your company provide the services under an existing contract vehicle, that the FDA may utilize the existing contract for the requested services found within the Draft STATEMENT OF OBJECTIVES
(SOO)?
☐ YES ☐ NO ☐ N/A
If yes is selected, please list contract number(s) and provide ordering instructions.
For questions 3 through 11, interested offerors must provide a description of their experience in providing the requested services, to include: contract numbers, performance period, contract value, customer name, and indication whether interested offeror acted as the prime or a sub under the contract.
3. Provide your company’s specific and relevant experience in providing the same or similar services as outlined in (Objectives) of the DRAFT SOO.
4. Provide your company’s specific and relevant experience in providing the same or similar services as outlined in Task 1 in the DRAFT SOO.
5. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 2 in the DRAFT SOO.
6. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 3 in the DRAFT SOO.
7. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 4 in the DRAFT SOO.
8. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 5 in the DRAFT SOO
9. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 6 in the DRAFT SOO.
10. Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 7 in the DRAFT SOO.
11 Provide your company’s specific and relevant experience in providing the same or similar services to those outlined in Task 8 in the DRAFT SOO.
12. Did you provide comments/feedback on the DRAFT SOO? Interested offerors are highly encouraged to provide comments/feedback on the DRAFT documents.
☐ YES ☐ NO
13. What NAICS code would your company recommend for this requirement? The FDA is considering 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
14. Can your company provide a list of all of tasks under your existing GSA Schedule contract, if applicable?
15. Does your company’s existing GSA schedule contract(s) cover the anticipated period of performance, if applicable.
16. List GSA schedule contract number(s) that would be applicable to this requirement.
File details come from the government source that posted it. Updated .